Impact BioMedical Inc.
IBO | AMEX
$4.14
+$0.34 (+8.95%)
At close: Nov 2, 2026, 3:59 PM ET
$3.99
+$0.19 (+5.00%)
Pre-market:
Nov 2, 2026, 9:17 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 10K | 20K | 3K | 12K | 624K | 1.32M | 2M | 2.67M | 2K | 2K | 1K | 201K | 3K | 1K | 2K | 101K | 33K | 46K | 73.3K | 73.3K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 59K | 67K | n/a | n/a | n/a | 782K | 782K | 972K | 4.88M | 4.83M | 4.82M | n/a | 3.79M |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | 17K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.16M | 5.08M | n/a | 2.97M |
Receivables | 197K | 199K | 203K | 214K | 200K | 204K | 184K | 142K | 263K | 331K | 331K | 204K | 298K | 205K | 16K | n/a | n/a | 197K | n/a | 97.29K |
Inventory | 62K | 63K | 63K | 485K | 486K | 489K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 51K | 95K | n/a | 206K | 171K | 172K | n/a | 365K | 42K | 2K | n/a | 96K | 47K | 183K | 104K | 252K | 250K | 44K | -73.3K | 85K |
Total Current Assets | 320K | 377K | 411K | 917K | 1.48M | 2.18M | 2.45M | 3.18M | 307K | 335K | 332K | 501K | 348K | 389K | 122K | 369K | 321K | 287K | n/a | 255.59K |
Property-Plant & Equipment | n/a | n/a | n/a | 13K | 14K | 16K | 17K | 282K | 284K | 285K | 287K | 289K | 290K | 279K | 276K | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | 16.43M | 16.71M | 16.99M | 17.28M | 17.57M | 17.85M | 17.81M | 43.18M | 43.46M | 43.74M | 44.01M | 44.29M | 44.57M | 44.85M | 45.13M | 45.41M | 45.96M | 46.24M | n/a | 46.8M |
Total Long-Term Assets | 16.43M | 16.71M | 16.99M | 17.29M | 17.58M | 17.87M | 17.84M | 43.52M | 43.81M | 44.02M | 44.3M | 44.58M | 45.64M | 45.91M | 46.38M | 50.29M | 55.96M | 56.14M | n/a | 53.56M |
Total Assets | 16.75M | 17.09M | 17.41M | 18.21M | 19.06M | 20.05M | 20.29M | 46.7M | 44.12M | 44.36M | 44.63M | 45.08M | 45.99M | 46.3M | 46.5M | 50.66M | 56.28M | 56.43M | n/a | 53.81M |
Account Payables | 467K | 374K | 347K | 576K | 554K | 615K | 314K | 1M | 986K | 1.02M | 832K | 476K | 301K | 186K | 539K | 44K | 55K | 115K | n/a | 55.62K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | 22.88M | 22.35M | 9.14M | 8.88M | 35K | 13.45M | 12.79M | 12.07M | 11.78M | 11.75M | 11.01M | 9.53M | 9.28M | 13.15M | 12.52M | n/a | 7.93M |
Other Current Liabilities | 1.33M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 61K | 47K | 230K | 6K | n/a | 50K | n/a | n/a | n/a | 6K | n/a | 10.99K |
Total Current Liabilities | 2.05M | 1.69M | 1.16M | 23.79M | 23.17M | 9.97M | 9.79M | 1.14M | 14.5M | 13.86M | 13.14M | 12.27M | 12.06M | 11.24M | 10.13M | 9.34M | 13.24M | 12.65M | n/a | 8M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.97M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.11M | 3.86M | n/a | -40.79M | n/a |
Total Long-Term Liabilities | 688K | 688K | 688K | 3.27M | 3.27M | 3.27M | 3.27M | 11.21M | 3.24M | 3.23M | 3.23M | 3.23M | 3.23M | 3.23M | 3.23M | 5.11M | 3.86M | 3.86M | -40.79M | 5.02M |
Total Liabilities | 2.73M | 2.38M | 1.85M | 27.06M | 26.44M | 13.24M | 13.05M | 12.34M | 17.73M | 17.09M | 16.37M | 15.5M | 15.29M | 14.48M | 13.83M | 14.45M | 17.1M | 16.5M | -40.79M | 13.02M |
Total Debt | n/a | n/a | n/a | 22.88M | 22.35M | 9.14M | 8.88M | 8.01M | 13.45M | 12.79M | 12.07M | 11.78M | 11.75M | 11.01M | 9.53M | 9.28M | 13.15M | 12.52M | n/a | 7.93M |
Book Value | 14.01M | 14.71M | 15.56M | -8.85M | -7.38M | 6.81M | 7.24M | 34.35M | 26.38M | 27.26M | 28.26M | 29.58M | 30.7M | 31.82M | 32.67M | 36.21M | 39.18M | 39.92M | 40.79M | 40.79M |
Book Value Per Share | 1.64 | 1.72 | 6.22 | -9.17 | -7.64 | 7.12 | 7.94 | 6.02 | 28.94 | 29.91 | 31 | 32.45 | 33.68 | 34.91 | 35.84 | 39.72 | 42.98 | 43.80 | 44.75 | 44.75 |
Common Stock | 108K | 108K | 105K | 12K | 12K | 12K | 11K | 11K | 10K | 10K | 10K | 70K | 125K | 125K | 125K | 125K | 125K | 125K | n/a | 125.07K |
Retained Earnings | -52.49M | -51.79M | -49.51M | -54.75M | -53.28M | -38.94M | -37.67M | -10.56M | -14.81M | -13.92M | -12.96M | -11.67M | -10.56M | -9.28M | -8.63M | -5.09M | -2.24M | -1.57M | n/a | -1.09M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 37.1M | n/a |
Shareholders Equity | 10.77M | 11.46M | 12.61M | -11.81M | -10.34M | 3.84M | 4.26M | 31.35M | 23.37M | 24.26M | 25.22M | 26.52M | 27.62M | 28.9M | 29.56M | 33.09M | 35.94M | 36.61M | 40.79M | 37.1M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 59K | 67K | n/a | n/a | n/a | 782K | 782K | 972K | 4.88M | 4.83M | 4.82M | n/a | 3.79M |
Add to Watchlist
Select watchlists to add or remove IBO